Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27899741 | 0.89 | THRB (0.42) | THRBLMNAALDH1A1 | |
| SCHEMBL1524615 | 0.88 | THRB (0.40) | THRBLMNAALDH1A1USP2KDM4E | |
| SCHEMBL10894591 | 0.86 | THRB (0.39) | THRBLMNAALDH1A1USP2KDM4E | |
| SCHEMBL11042187 | 0.84 | USP2 (0.37) | THRBLMNAALDH1A1USP2KDM4E | |
| SCHEMBL10786690 | 0.84 | USP2 (0.37) | THRBLMNAALDH1A1USP2KDM4E | |
| SCHEMBL1357902 | 0.83 | LMNA (0.44) | THRBLMNAALDH1A1USP2CYP1A2 | |
| SCHEMBL1206579 | 0.83 | USP2 (0.44) | THRBLMNAALDH1A1USP2CYP1A2 | |
| SCHEMBL17237504 | 0.81 | USP2 (0.34) | THRBLMNAALDH1A1USP2CYP1A2 | |
| SCHEMBL1619852 | 0.79 | LMNA (0.40) | THRBLMNAALDH1A1USP2CYP1A2 | |
| SCHEMBL11236220 | 0.79 | TDP1 (0.40) | THRBLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3215552-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | Vantage Specialty Chemicals, Inc. (US) | 2017-09-13 | — | — | EP | claimed |
| WO-2016040956-A1 | DERIVATIVES OF 1,3-PROPANEDIOL | VANTAGE SPECIALTY CHEMICALS, INC. (US) | 2016-03-17 | — | — | WO | claimed |
| US-20240026407-A1 | MODIFICATION OF SAPONINS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-01-25 | — | — | US | disclosed |
| WO-2023242187-A1 | ENZYMATIC MODIFICATION OF SAPONINS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-12-21 | — | — | WO | disclosed |
| US-20220126258-A1 | COMPOSITIONS AND FORMULATIONS FOR ENTRAPPING PROTEIN ON A SURFACE | PURE TRANSPLANT SOLUTIONS L L C (US) | 2022-04-28 | — | — | US | disclosed |
| US-11260363-B2 | Compositions and methods for entrapping protein on a surface | PURE TRANSPLANT SOLUTIONS L.L.C. (US) | 2022-03-01 | — | — | US | disclosed |
| US-20200147580-A1 | COMPOSITIONS AND METHODS FOR ENTRAPPING PROTEIN ON A SURFACE | PURE TRANSPLANT SOLUTIONS L.L.C. | 2020-05-14 | — | — | US | disclosed |
| US-10556218-B2 | Compositions and methods for entrapping protein on a surface | PURE TRANSPLANT SOLUTIONS L.L.C. (US) | 2020-02-11 | — | — | US | disclosed |
| US-20190039041-A1 | COMPOSITIONS AND METHODS FOR ENTRAPPING PROTEIN ON A SURFACE | GENOMICS USA, INC. (US) | 2019-02-07 | — | — | US | disclosed |
| EP-2997037-B1 | USE OF A COMPOSITION FOR ENTRAPPING A PROTEIN ON A SURFACE | GENOMICS USA INC (US) | 2018-11-21 | — | — | EP | disclosed |
| US-10105674-B2 | Compositions and methods for entrapping protein on a surface | GENOMICS USA, INC. (US) | 2018-10-23 | — | — | US | disclosed |
| EP-1581617-B8 | METHODS FOR PRODUCING END-PRODUCTS FROM CARBON SUBSTRATES | DANISCO US INC (US) | 2011-03-23 | — | — | EP | disclosed |
| US-20100285548-A1 | Process And Apparatus For The Microbial Production Of A Specific Product And Methane | AGRAFERM TECHNOLOGIES AG (DE) | 2010-11-11 | — | — | US | disclosed |
| US-20090075347-A1 | Production of Bacterial Strains Cross Reference To Related Applications | GENENCOR INTERNATIONAL, INC. | 2009-03-19 | — | — | US | disclosed |
| WO-2004109729-A1 | LOW FREEZING ELECTROLYTE FOR AN ELECTROLYTIC CAPACITOR | KEMET ELECTRONICS CORPORATION (US) | 2004-12-16 | — | — | WO | disclosed |
| US-5164459-A | METHOD FOR TREATING THE SURFACE OF AN ABSORBENT RESIN | NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) | 1992-11-17 | — | — | US | disclosed |
| EP-0357673-A4 | ANTIBIOTIC REUTERIN | — | 1991-09-25 | — | — | EP | disclosed |
| EP-0357673-A1 | ANTIBIOTIC REUTERIN. | PROBIOLOGICS INT INC (US) | 1990-03-14 | — | — | EP | disclosed |
| CN-1032618-A | TOBACCO SMOKING ARTICLE | BLOCKERS C A INC (US) | 1989-05-03 | — | — | CN | disclosed |
| WO-1988008452-A1 | ANTIBIOTIC REUTERIN | PROBIOLOGICS INTERNATIONAL, INC. (US) | 1988-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240026407-A1 | MODIFICATION OF SAPONINS | GBA3, SI, MANBA | THRB 2563/4885LMNA 1587/4885ALDH1A1 2918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.